Literature DB >> 23533288

High sensitivity of diffusion-weighted MR imaging for the detection of liver metastases from neuroendocrine tumors: comparison with T2-weighted and dynamic gadolinium-enhanced MR imaging.

Gaspard d'Assignies1, Priscilla Fina, Onorina Bruno, Marie-Pierre Vullierme, Florence Tubach, Valérie Paradis, Alain Sauvanet, Philippe Ruszniewski, Valérie Vilgrain.   

Abstract

PURPOSE: To compare the sensitivity and specificity of diffusion-weighted (DW) magnetic resonance (MR) imaging for identifying liver metastases from neuroendocrine tumor (NET) to those of T2-weighted fast spin-echo (FSE) and three-dimensional dynamic gadolinium-enhanced MR imaging, with surgical and histopathologic findings as the reference standard.
MATERIALS AND METHODS: This retrospective study was approved by institutional review board, and informed consent was waived. Fifty-nine patients with NETs (41 patients with 162 liver metastases, and 18 control subjects with no liver metastases) underwent MR imaging that included DW, T2-weighted FSE, and dynamic gadolinium-enhanced MR sequences. Images were retrospectively reviewed by two abdominal radiologists, independently, for the detection and characterization of liver metastases. MR findings were compared with histopathologic and intraoperative ultrasonography findings for metastasis on a lesion-by-lesion basis to determine the sensitivity of each MR sequence alone and combined. Specificity was calculated by using the control population. Interreader agreement for each MR sequence and McNemar test were also calculated.
RESULTS: There was excellent agreement between observers 1 and 2 for characterizing liver metastases at per-lesion analysis (κ coefficient: 0.86-1.00). DW MR was more sensitive (observer 1: sensitivity, 71.6% [116 of 162], 95% confidence interval [CI]: 64.2%, 78.0%; observer 2: sensitivity, 71.0% [115 of 162], 95% CI: 63.6%, 77.4%) than T2-weighted FSE (observer 1: sensitivity, 55.6% [90 of 162], 95% CI: 47.9%, 63.0%; observer 2: sensitivity, 55.6% [90 of 162], 95% CI: 47.9%, 63.0%) and dynamic gadolinium-enhanced MR (observer 1: sensitivity, 47.5% [77 of 162], 95% CI: 34.0%, 55.2%; observer 2: sensitivity, 48.1% [78 of 162], 95% CI: 40.6%, 55.8%) (P < .001 for both, McNemar test). The specificity of these sequences ranged from 88.9% to 100% (DW MR vs T2-weighted FSE MR: P > .99, DW MR vs dynamic gadolinium-enhanced MR: P = .61, and T2-weighted FSE MR vs dynamic gadolinium-enhanced MR: P = .61, McNemar test).
CONCLUSION: DW MR imaging was more sensitive for the detection and characterization of liver metastases from NETs than T2-weighted FSE and dynamic gadolinium-enhanced MR imaging and should be systematically performed.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23533288     DOI: 10.1148/radiol.13121628

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  45 in total

1.  Diagnostic Accuracy of Preoperative Gadoxetic Acid-enhanced 3-T MR Imaging for Malignant Liver Lesions by Using Ex Vivo MR Imaging-matched Pathologic Findings as the Reference Standard.

Authors:  Eduardo A C Costa; Guilherme M Cunha; Emmanuil Smorodinsky; Irene Cruite; An Tang; Robert M Marks; Lisa Clark; Tanya Wolfson; Anthony Gamst; Jason K Sicklick; Alan Hemming; Michael R Peterson; Michael S Middleton; Claude B Sirlin
Journal:  Radiology       Date:  2015-04-15       Impact factor: 11.105

Review 2.  Lesion discrimination with breath-hold hepatic diffusion-weighted imaging: a meta-analysis.

Authors:  Zhi-Guang Chen; Li Xu; Si-Wei Zhang; Yan Huang; Rui-Huan Pan
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

3.  The value of liver magnetic resonance imaging in patients with findings of resectable pancreatic cancer on computed tomography.

Authors:  Cindy Chew; Patrick J O'Dwyer
Journal:  Singapore Med J       Date:  2016-06       Impact factor: 1.858

4.  MR imaging of primary hepatic neuroendocrine neoplasm and metastatic hepatic neuroendocrine neoplasm: a comparative study.

Authors:  RuoFan Sheng; YanHong Xie; MengSu Zeng; Yuan Ji; ShengXiang Rao; CaiZhong Chen
Journal:  Radiol Med       Date:  2015-04-24       Impact factor: 3.469

Review 5.  [Diffusion-weighted imaging-diagnostic supplement or alternative to contrast agents in early detection of malignancies?]

Authors:  S Bickelhaupt; C Dreher; F König; K Deike-Hofmann; D Paech; H P Schlemmer; T A Kuder
Journal:  Radiologe       Date:  2019-06       Impact factor: 0.635

6.  Semi-quantitative visual assessment of hepatic tumor burden can reliably predict survival in neuroendocrine liver metastases treated with transarterial chemoembolization.

Authors:  Yan Luo; Sanaz Ameli; Ankur Pandey; Pegah Khoshpouri; Mounes Aliyari Ghasabeh; Pallavi Pandey; Zhen Li; Daoyu Hu; Ihab R Kamel
Journal:  Eur Radiol       Date:  2019-05-09       Impact factor: 5.315

7.  Fast non-enhanced abdominal examination protocols in PET/MRI for patients with neuroendocrine tumors (NET): comparison to multiphase contrast-enhanced PET/CT.

Authors:  Ferdinand Seith; Christina Schraml; Gerald Reischl; Konstantin Nikolaou; Christina Pfannenberg; Christian la Fougère; Nina Schwenzer
Journal:  Radiol Med       Date:  2018-06-30       Impact factor: 3.469

8.  Neuroendocrine tumor of gallbladder with liver and retroperitoneal metastases and a good response to the chemotherapeutical treatment.

Authors:  Liliana Chiorean; Adrian Bartos; Doris Pelau; Dana Iancu; Tudor Ciuleanu; Rares Buiga; Irinel Oancea; Angelica Mangrau; Cornel Iancu; Radu Badea
Journal:  J Med Ultrason (2001)       Date:  2014-10-25       Impact factor: 1.314

9.  Prognostic value of CT findings to predict survival outcomes in patients with pancreatic neuroendocrine neoplasms: a single institutional study of 161 patients.

Authors:  Dong Wook Kim; Hyoung Jung Kim; Kyung Won Kim; Jae Ho Byun; So Yeon Kim; Ki Byung Song; Nikhil H Ramaiya; Sree Harsha Tirumani; Seung-Mo Hong
Journal:  Eur Radiol       Date:  2015-08-08       Impact factor: 5.315

10.  Prospective comparison of whole-body MRI with diffusion-weighted and conventional imaging for the follow-up of neuroendocrine tumors.

Authors:  Maximilien Minon; Clothilde Soriano; David Morland; Thomas Walter; Côme Lepage; Antoine Tabarin; Mathilde Deblock; Pascal Rousset; Coralie Barbe; Christine Hoeffel; Guillaume Cadiot
Journal:  Endocrine       Date:  2019-09-28       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.